desipramine in four patients.

Desipramine treatment of cocaine dependence in methadone-maintained patients.

Desipramine treatment in panic disorder.

Desipramine relieves postherpetic neuralgia.

Growth deficits and desipramine.

Fluoxetine inhibits desipramine metabolism.

Desipramine side-effect.

Combining fluoxetine with desipramine.

A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or imipramine.

Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine.

Desipramine for neuropathic pain in adults.

Fluvoxamine versus desipramine: comparative polysomnographic effects.

Ventricular tachycardia associated with desipramine and thioridazine.

Adipose tissue distribution and chemical structure of basic lipophilic drugs: desipramine, N-acetyl desipramine, and haloperidol.

Platelet alpha 2-adrenergic receptors in depressed patients and healthy volunteers: the effects of desipramine.

Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients.

Desipramine induces cardiac beta-adrenergic sensitivity decrease in major depressed patients without relationship to therapeutic response.

Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse.

Value of the DST for predicting response of patients with major depression to hospitalization and desipramine.

Pancreatic pseudocyst: management in fifty-four patients.

Cytomegalovirus encephalitis in four immunocompetent patients.

Clinical pharmacokinetics of imipramine and desipramine.

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.

A controlled trial of adinazolam versus desipramine in geriatric depression.

Lofexidine and desipramine: Interaction results in breakthrough opioid withdrawal symptoms.

Suggest Documents

Desipramine treatment of cocaine dependence in methadone-maintained patients.

Desipramine treatment in panic disorder.

Desipramine relieves postherpetic neuralgia.

Growth deficits and desipramine.

Fluoxetine inhibits desipramine metabolism.

Desipramine side-effect.

Combining fluoxetine with desipramine.

A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or imipramine.

Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine.

Desipramine for neuropathic pain in adults.

Fluvoxamine versus desipramine: comparative polysomnographic effects.

Ventricular tachycardia associated with desipramine and thioridazine.

Adipose tissue distribution and chemical structure of basic lipophilic drugs: desipramine, N-acetyl desipramine, and haloperidol.

Platelet alpha 2-adrenergic receptors in depressed patients and healthy volunteers: the effects of desipramine.

Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients.

Desipramine induces cardiac beta-adrenergic sensitivity decrease in major depressed patients without relationship to therapeutic response.

Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse.

Value of the DST for predicting response of patients with major depression to hospitalization and desipramine.

Pancreatic pseudocyst: management in fifty-four patients.

Cytomegalovirus encephalitis in four immunocompetent patients.

Clinical pharmacokinetics of imipramine and desipramine.

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.

A controlled trial of adinazolam versus desipramine in geriatric depression.

Lofexidine and desipramine: Interaction results in breakthrough opioid withdrawal symptoms.

desipramine in four patients.

Recommend Documents

Follow Us